Chapter 5. Treatment with antihypertensive drugs

This publication has 138 references indexed in Scilit:

• Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial
  The Lancet, 2013
• 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
  Arthritis Care & Research, 2012
• Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study
  BMJ, 2012
• Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension
  Journal Of Hypertension, 2011
• Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
  New England Journal of Medicine, 2011
• Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
  BMJ, 2009
• Low-Dose Quadruple Antihypertensive Combination
  Hypertension, 2007
• Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)
  Heart, 2007
• Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine
  BMJ, 2006
• Withdrawal syndrome following cessation of antihypertensive drug therapy
  International Journal Of Clinical Practice, 2005